The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,508.77 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the provision of 4566703682 XTANDI 80 MG TABLET 60S. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at $499,999,999 and valid through November 2026, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, enabling DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.
Generated 3/13/25, 10:11 AM